PDS Biotechnology Corporation (PDSB) Operating income 2016–2025
PDS Biotechnology Corporation (PDSB) annual operating income history from SEC filings — each fiscal year as reported.
-$31.5MFY2025 · since FY2016: -$39.5M → -$31.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$31.5M | +13.2% |
| FY2024 | -$36.3M | +15.6% |
| FY2023 | -$43.0M | -3.3% |
| FY2022 | -$41.7M | -94.4% |
| FY2021 | -$21.4M | -43.9% |
| FY2020 | -$14.9M | +29.2% |
| FY2019 | -$21.0M | -476.9% |
| FY2018 | -$3.6M | +93.0% |
| FY2017 | -$52.0M | -31.5% |
| FY2016 | -$39.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice